CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
11.13
-0.49 (-4.22%)
At close: Oct 31, 2025, 4:00 PM EDT
11.18
+0.05 (0.45%)
After-hours: Oct 31, 2025, 7:49 PM EDT
CorMedix Stock Forecast
Stock Price Forecast
The 7 analysts that cover CorMedix stock have a consensus rating of "Strong Buy" and an average price target of $17.86, which forecasts a 60.47% increase in the stock price over the next year. The lowest target is $12 and the highest is $22.
Price Target: $17.86 (+60.47%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CorMedix stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 3 | 3 | 3 | 4 | 4 |
| Hold | 0 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 7 | 8 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $21 → $22 | Buy | Maintains | $21 → $22 | +97.66% | Oct 21, 2025 |
| D. Boral Capital | D. Boral Capital | Hold → Strong Buy Upgrades $14 | Hold → Strong Buy | Upgrades | $14 | +25.79% | Oct 20, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $22 | Buy | Reiterates | $22 | +97.66% | Sep 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $17 | Strong Buy | Maintains | $20 → $17 | +52.74% | Aug 8, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jun 30, 2025 |
Financial Forecast
Revenue This Year
281.21M
from 43.47M
Increased by 546.87%
Revenue Next Year
425.98M
from 281.21M
Increased by 51.48%
EPS This Year
2.09
from -0.30
EPS Next Year
2.54
from 2.09
Increased by 21.33%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 361.0M | 537.6M | |||
| Avg | 281.2M | 426.0M | |||
| Low | 244.2M | 319.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 730.4% | 91.2% | |||
| Avg | 546.9% | 51.5% | |||
| Low | 461.8% | 13.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.96 | 3.06 | |||
| Avg | 2.09 | 2.54 | |||
| Low | 1.49 | 2.15 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 46.2% | |||
| Avg | - | 21.3% | |||
| Low | - | 2.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.